FIIMX
Price
$23.90
Change
-$0.37 (-1.52%)
Updated
Sep 6 closing price
VIEIX
Price
$129.08
Change
-$2.22 (-1.69%)
Updated
Sep 6 closing price
Ad is loading...

FIIMX vs VIEIX

Header iconFIIMX vs VIEIX Comparison
Open Charts FIIMX vs VIEIXBanner chart's image
Fidelity Advisor Mid Cap II I
Price$23.90
Change-$0.37 (-1.52%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Instl
Price$129.08
Change-$2.22 (-1.69%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FIIMX vs VIEIX Comparison Chart
Loading...
VS
FIIMX vs. VIEIX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIIMX is a Hold and VIEIX is a Buy.

FUNDAMENTALS
Fundamentals
VIEIX has more cash in the bank: 107B vs. FIIMX (1.56B). VIEIX pays higher dividends than FIIMX: VIEIX (1.21) vs FIIMX (0.35). FIIMX was incepted earlier than VIEIX: FIIMX (20 years) vs VIEIX (27 years). FIIMX is a more actively managed with annual turnover of: 47.00 vs. VIEIX (11.00). FIIMX has a lower initial minimum investment than VIEIX: FIIMX (0) vs VIEIX (5000000). VIEIX annual gain was more profitable for investors over the last year : 15.91 vs. FIIMX (14.88). VIEIX return over 5 years is better than : 50.74 vs. FIIMX (32.01).
FIIMXVIEIXFIIMX / VIEIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years27 years-
Gain YTD9.1775.473168%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B107B1%
Annual Yield % from dividends0.351.2129%
Returns for 1 year14.8815.9194%
Returns for 3 years-9.24-9.17101%
Returns for 5 years32.0150.7463%
Returns for 10 years10.72106.5710%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KORE2.430.22
+9.95%
KORE Group Holdings
USPH86.78N/A
N/A
US Physical Therapy
SENEA60.13-0.33
-0.55%
Seneca Foods Corp
REGN1150.65-28.72
-2.44%
Regeneron Pharmaceuticals
TNET97.19-2.60
-2.61%
Trinet Group